Datasets:
CDR3
string | peptide
string | HLA
string | HLA_sequence
string | label
int64 |
|---|---|---|---|---|
CSARTEGAEAFF
|
CVNGSCFTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSYWTGSSAETQYF
|
CVNGSCFTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSRAGTGYNEQFF
|
KTFPPTEPK
|
A*11:01
|
TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE
| 1
|
CASSPSVYFEVSGANVLTF
|
KTFPPTEPK
|
A*11:01
|
TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE
| 1
|
CASSEVGVFEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSLGVNTEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSFRDLSSYNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSPALGDQETQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASRPGQHTGELFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSVEEGLQTGELFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSAETGNTEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSEVADYNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSLEGDTEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSEFQGDNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSDGSFNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSVGDLLTGELFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CATSDLEGWTQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CANPPGSSYNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSATRLAGGPTDTQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSVALGNQETQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSQAGSSYEQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSAEQGNTEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSPGTGGNEQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSLDLPGPEGETQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSAEDGNSPLHF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CAWSPAGLAMYEQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSEAGGPGYEQYF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSVRDISTNEKLFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CSAESGNTEAFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSSPSGVYNEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSVDLKAGEEGEQFF
|
DATYQRTRALVR
|
A*68:01
|
TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE
| 1
|
CASSLRGGQSYEQYF
|
MLYQHLLPL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSQWDNQPQHF
|
WMRLLPLL
|
B*08:01
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CAISEGAPNTEAFF
|
FGDHPGHSY
|
A*01:01
|
TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE
| 1
|
CASSGGAVAPSEQFF
|
GLCTLVAML
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSHTTGDDYGYTF
|
KSKRTPMGF
|
B*57:01
|
TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE
| 1
|
CASSLTSTRQPQHF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSPPQFTEAFF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSSSLVVEQYF
|
RAQAPPPSW
|
B*57:01
|
TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE
| 1
|
CASSFPGQGNTQYF
|
RAQAPPPSW
|
B*57:01
|
TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE
| 1
|
CASSVASGQLYGYTF
|
RLGPVQNEV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASRVGQNYNSPLHF
|
RLGPVQNEV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSQDAPGQGSDEQFF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSPGTGGPFSEQYF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSLVTGNQPQHF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSEGDRGLANEKLFF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CASSLGRAGYGETQYF
|
HYPYRLWHY
|
A*03:01
|
TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE
| 1
|
CAISESSSGNNEQFF
|
ATDALMTGF
|
A*01:01
|
TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE
| 1
|
CASSQAPPGQGVDIQYF
|
GPRLGVRAT
|
B*07:02
|
TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE
| 1
|
CATSGDTQYF
|
KLVAMGINAV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSLNWGSGYNEQFF
|
KLVAMGINAV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSLEGGDEQFF
|
KLVAMGINAV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSVETTGELFF
|
KLVAMGINAV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASIGWGELFF
|
KLVAMGINAV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSEGLWQVGDEQYF
|
HMTEVVRHC
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CAISELVTGDSPLHF
|
HMTEVVRHC
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSIQQGADTQYF
|
HMTEVVRHC
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSLGEGRVDGYTF
|
GADGVGKSAL
|
C*08:02
|
TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE
| 1
|
CASSDPGTEAFF
|
GADGVGKSAL
|
C*08:02
|
TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE
| 1
|
CASSFGQSSTYGYTF
|
GADGVGKSAL
|
C*08:02
|
TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE
| 1
|
CASSLGRASNQPQHF
|
GADGVGKSAL
|
C*08:02
|
TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE
| 1
|
CASSLGQTNYGYTF
|
GADGVGKSAL
|
C*08:02
|
TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE
| 1
|
CASSSQGGYGYTF
|
KVDPIGHVY
|
A*01:01
|
TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE
| 1
|
CASSFDRGYGYTF
|
KVDPIGHVY
|
A*01:01
|
TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE
| 1
|
CASSLSGGLLRTGELFF
|
FVVPYMIYLL
|
C*03:03
|
TIGFFDAPRGPPWEQPEDQDVRHIGINDWAAAQE
| 1
|
CASSGRVTGGFYNEQFF
|
VQIISCQY
|
A*30:02
|
TLGFFDAQRRPPWEQPEDQDEGHIGINDWAAAQE
| 1
|
CASSFGGAYEQYF
|
VQIISCQY
|
B*15:01
|
TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE
| 1
|
CASSLVSPSEQFF
|
YLSNIIPAL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSLFTGTNEQFF
|
QLCDVMFYL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSLDQGAQDNEQFF
|
YLYDRLLRV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CATSFAPGQGEHGYTF
|
LYPEFIASI
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASSTSTGQGWHYGYTF
|
MLIGIPVYV
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASRPSRGTNYGYTF
|
KLYGLDWAEL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSERGMVEAFF
|
KLYGLDWAEL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSPRNLGPSGSYEQYF
|
KLYGLDWAEL
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSQNYEQYF
|
ALDPHSGHFV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSYSWGAGYEQYF
|
ALDPHSGHFV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASTPTGAYEQYF
|
ALDPHSGHFV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CSAGTGELFF
|
ALDPHSGHFV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CSARVGDTGELFF
|
ALSPVIPHI
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSYDSTTGELFF
|
ALSPVIPHI
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASTPGGYEQYF
|
KLFEFLVYGV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSQGYEQYF
|
KLFEFLVYGV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSPAALSGAYEQYF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSRRSSGELFF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSRDSALWISTDTQYF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASRLGTGPEAFF
|
EAAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSFGLGTEAFF
|
EAAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSPPGLSGNIQYF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSPGTLADTQYF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASAWGGMTNEQYF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSETGGTEAFF
|
EAAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSDQGLGTEAFF
|
EAAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASRSLGQGAEKLFF
|
ELAGIGILTV
|
A*02:01
|
TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE
| 1
|
CASSRGTLHYGYTF
|
FYGKTILWF
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASSLGQGCSNQPQHF
|
FYGKTILWF
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASSLGAAPQETQYF
|
FYGKTILWF
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASSTRVVAGNNEQFF
|
FYGKTILWF
|
A*24:02
|
TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE
| 1
|
CASSPGVGTEAFF
|
EFTVSGNIL
|
B*40:01
|
TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE
| 1
|
CASSPGASYEQYF
|
ESITGSLGPLL
|
B*40:01
|
TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE
| 1
|
Temporal OOD Dataset for TCR-pMHC Binding Prediction
Dataset Description
The Temporal OOD (Out-of-Distribution) Dataset evaluates TCR-pMHC binding prediction models under temporal shift. This dataset contains SARS-CoV-2 T cell receptor sequences collected during the COVID-19 pandemic, providing a natural test of model generalization to time-lagged data.
Key Features
- Temporal Shift Testing: Data collected after training set construction
- COVID-19 Focus: SARS-CoV-2 T cell repertoire from pandemic
- Complete PMT Data: All samples include CDR3, peptide, and HLA
- Multi-Laboratory: Compiled from multiple research laboratories
- Experimentally Validated: All TCR-pMHC interactions experimentally annotated
Dataset Details
Construction Method
This dataset follows the out-of-date testing protocol introduced in FusionPMT, using the external SARS-CoV-2 repertoire from VDJdb's recent update. The sequences were:
- Collected during COVID-19 pandemic by multiple laboratories
- Experimentally annotated for peptide and HLA specificities
- Filtered using standard quality control rules
- Deduplicated to remove redundant entries
- Validated for completeness
Statistics
- Total Samples: 13979
- Positive Samples: 1272 (9.1%)
- Negative Samples: 12707 (90.9%)
- Unique TCR Sequences: N/A
- Unique Peptide Epitopes: 239
- Unique HLA Alleles: 48
Data Format
CSV file with the following columns:
| Column | Type | Description | Required |
|---|---|---|---|
| CDR3 | string | TCR CDR3beta amino acid sequence | Yes |
| peptide | string | Peptide amino acid sequence | Yes |
| HLA | string | HLA allele (e.g., A*02:01) | Yes |
| label | int | Binding label (1=binder, 0=non-binder) | Yes |
| HLA_sequence | string | HLA pseudo-sequence | Optional |
Peptide Length Distribution
- 7aa: 54 samples (0.4%)\n- 8aa: 1016 samples (7.3%)\n- 9aa: 9287 samples (66.4%)\n- 10aa: 2662 samples (19.0%)\n- 11aa: 729 samples (5.2%)\n- 12aa: 137 samples (1.0%)\n- 13aa: 42 samples (0.3%)\n- 20aa: 52 samples (0.4%)
Label Distribution
- Binders (label=1): 1272 samples
- Non-binders (label=0): 12707 samples
- Imbalance Ratio: ~1:10.0 (positive:negative)
Usage
Load with Hugging Face Datasets
from datasets import load_dataset
dataset = load_dataset("YYJMAY/temporal-ood")
df = dataset['train'].to_pandas()
Load with Pandas
import pandas as pd
from huggingface_hub import hf_hub_download
file_path = hf_hub_download(
repo_id="YYJMAY/temporal-ood",
filename="temporal_ood.csv",
repo_type="dataset"
)
df = pd.read_csv(file_path)
Use with SPRINT Framework
from sprint.core.dataset_manager import DatasetManager
manager = DatasetManager()
dataset_config = {
'hf_repo': 'YYJMAY/temporal-ood',
'files': ['temporal_ood.csv'],
'test': 'temporal_ood.csv'
}
files = manager.get_dataset('temporal_ood', dataset_config)
test_file = files['test']
Scientific Context
Temporal Shift Challenge
This dataset addresses a critical challenge in machine learning for immunology: temporal generalization. Models trained on historical data must generalize to new sequences collected at later time points. The COVID-19 pandemic provides a unique natural experiment for this evaluation.
Why Temporal OOD Matters
- Real-world Deployment: Clinical applications require models that work on future data
- Emerging Pathogens: New disease outbreaks generate novel epitopes
- Distribution Drift: Immune repertoires evolve over time
- Model Robustness: Tests whether models learn fundamental biology vs. dataset artifacts
Biological Significance
- SARS-CoV-2 Epitopes: Includes key viral peptides recognized by T cells
- Pandemic Diversity: Represents diverse patient populations and disease stages
- Laboratory Consensus: Multi-laboratory validation increases reliability
- Clinical Relevance: Direct connection to COVID-19 immune response research
Task Compatibility
- PMT Task: Yes (all samples have CDR3)
- PM Task: Yes (peptide-HLA pairs available)
All 13979 entries are suitable for TCR-peptide-MHC (PMT) binding prediction.
Quality Control
Filtering Rules Applied
- Removed entries with missing CDR3, peptide, or HLA
- Removed duplicate (CDR3, peptide, HLA, label) combinations
- Validated label values (0 or 1 only)
- Checked for empty strings in critical columns
- Verified HLA sequence availability
Data Integrity
- No Missing Values: All required columns complete
- No Duplicates: 659 duplicates removed during preprocessing
- Valid Labels: All labels are binary (0 or 1)
- Standardized Format: Consistent with other SPRINT datasets
Comparison with Training Data
This dataset intentionally differs from training data in temporal dimension:
| Aspect | Training Data | Temporal OOD |
|---|---|---|
| Collection Period | Pre-pandemic | During COVID-19 pandemic |
| Epitope Source | Various pathogens | SARS-CoV-2 dominant |
| Data Vintage | Historical | Recent/contemporary |
| Distribution | Established | Time-shifted |
Benchmark Results
This dataset is used to evaluate multiple TCR-pMHC binding prediction methods in the SPRINT benchmark suite. Expected performance characteristics:
- Difficulty: Moderate to challenging due to temporal shift
- Baseline: Random classifier ~9.1% (positive class frequency)
- Evaluation Metrics: AUC, AUPR, F1, Precision, Recall
Citation
If you use this dataset, please cite:
@dataset{temporal_ood_2024,
title={Temporal OOD Dataset for TCR-pMHC Binding Prediction},
author={SPRINT Framework Contributors},
year={2024},
note={SARS-CoV-2 T cell repertoire data from VDJdb},
url={https://huggingface.co/datasets/YYJMAY/temporal-ood}
}
And the original VDJdb paper:
@article{goncharov2022vdjdb,
title={VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium},
author={Goncharov, Mikhail and others},
journal={Nucleic Acids Research},
year={2022}
}
Related Datasets
- Allelic OOD: Tests generalization to rare HLA alleles
- Modality OOD: Tests cross-modality generalization (BA ↔ EL)
- FusionPMT Training: Original training data
Limitations
- COVID-19 Bias: Heavy emphasis on SARS-CoV-2 epitopes
- Temporal Specificity: Limited to pandemic time period
- Imbalanced Labels: Negative samples dominate (~87%)
- HLA Coverage: 48 alleles, may not cover all population diversity
License
MIT License - Free for academic and commercial use
Contact
For questions, issues, or contributions:
- Dataset repository: YYJMAY/temporal-ood
- SPRINT framework: https://github.com/Computational-Machine-Intelligence/SPRINT
Acknowledgments
- VDJdb team for SARS-CoV-2 repertoire data
- Multiple laboratories contributing T cell sequences during COVID-19 pandemic
- FusionPMT authors for temporal OOD protocol design
- Downloads last month
- 25